Table 1.
Fully vaccinated | Unvaccinated | |||||||
---|---|---|---|---|---|---|---|---|
Primary | Household | Secondary | SAR | Primary | Household | Secondary | SAR | |
Cases | Contacts | Cases | (%) | Cases | Contacts | Cases | (%) | |
Total | 8262 | 26,098 | 3816 | 15 | 16,431 | 27,486 | 7815 | 28 |
Sex | ||||||||
Male | 4001 | 12,868 | 1711 | 13 | 8301 | 13,801 | 3626 | 26 |
Female | 4261 | 13,230 | 2105 | 16 | 8130 | 13,685 | 4189 | 31 |
Age | ||||||||
0–9 years | 0 | 0 | 0 | – | 3668 | 11,687 | 3198 | 27 |
10–19 years | 721 | 3482 | 181 | 5 | 4859 | 5742 | 1720 | 30 |
20–29 years | 1368 | 2633 | 224 | 9 | 4131 | 3756 | 983 | 26 |
30–39 years | 1131 | 4434 | 730 | 16 | 2316 | 3014 | 1028 | 34 |
40–49 years | 1676 | 7961 | 1210 | 15 | 923 | 2015 | 585 | 29 |
50–59 years | 1601 | 4808 | 686 | 14 | 407 | 994 | 247 | 25 |
60–69 years | 1085 | 1893 | 445 | 24 | 109 | 211 | 42 | 20 |
70–79 years | 680 | 887 | 340 | 38 | 18 | 67 | 12 | 18 |
Household Size | ||||||||
2 persons | 3859 | 4832 | 1209 | 25 | 3704 | 2731 | 812 | 30 |
3 persons | 1809 | 5660 | 702 | 12 | 4092 | 5132 | 1402 | 27 |
4 persons | 1785 | 9246 | 1204 | 13 | 5080 | 9416 | 2801 | 30 |
5 persons | 643 | 4980 | 572 | 11 | 2762 | 7260 | 2029 | 28 |
6 persons | 166 | 1380 | 129 | 9 | 793 | 2947 | 771 | 26 |
Vaccination | ||||||||
Vaxzevria | 514 | 1398 | 229 | 16 | – | – | – | – |
Janssen | 529 | 546 | 108 | 20 | – | – | – | – |
Spikevax | 366 | 2441 | 243 | 10 | – | – | – | – |
Comirnaty | 6853 | 21,713 | 3236 | 15 | – | – | – | – |
The secondary attack rate (SAR) is expressed in percentages. Primary cases and household contacts are here shown by groups of sex, age, household size and vaccination status, independent of each other. Table S1 provides summary statistics for contacts and secondary cases are grouped based on the primary case characteristics.